Telomerase activity in ductal carcinoma in situ of the breast (original) (raw)

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Weiner T, Cance WG: Molecular mechanism involved in tumorigenesis and their surgical implications. Am J Surg 176: 428–434, 1994
    Google Scholar
  2. Pilot HC: The molecular biology of carcinogenesis. Cancer 72 (Suppl 3): 962–970, 1993
    Google Scholar
  3. Bieche I, Lidereau R: Genetic alterations in breast cancer. Genes, Chrom Cancer 14: 227–251, 1995
    Google Scholar
  4. Lagios MD: Duct carcinoma in situ. Surg Clin N A 70: 853–871, 1990
    Google Scholar
  5. Welsh HG, Black WC: Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more cancer can we found. Ann Int Med 127: 1023–1028, 1997
    Google Scholar
  6. Perin T, Canzolieri V, Massarut S, et al.: Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast. Eur J Cancer 32A: 1148–1155, 1996
    Google Scholar
  7. Marsh KL and Varley JM: Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry. Br J Cancer 77: 1460–1468, 1998
    Google Scholar
  8. Bobrow LG, Happerfield LC, Gregory WM, Springhall RG, Millis RR: The classification of ductal carcinoma in situ and its association with biological markers. Semin Diagnost Pathol 11: 199–207, 1994
    Google Scholar
  9. Mack L, Kerkvliet N, Doig G, et al.: Relationship of a new histological cathegorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-_erb_B-2, bcl-2 and Ki-67. Hum Pathol 28: 947–979, 1997
    Google Scholar
  10. Kyo S, Takakura M, Tanaka M, et al.: Quantitative differences in telomerase activity among malignant, premalignant and benign ovarian lesions. Clin Cancer Res 4: 399–405, 1998
    Google Scholar
  11. Cheng AJ, Tang R, Wang JY, See LC, Wang TC: Possible role of telomerase activation in the cancer predisposition of patients with hereditary non-polyposis colorectal cancers. J Natl Cancer Inst 90: 316–321, 1998
    Google Scholar
  12. Wisman GB, Hollema H, de Long S, et al.: Telomerase activity as biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smears. J Clin Oncol 16: 2238–2245, 1998
    Google Scholar
  13. Hiyama E, Hiyama K, Shay JW, Yokoyama T: Telomerase activity and expression of its components in human neuroblastoma. Proc Am Assoc Cancer Res 39: 570, 1998
    Google Scholar
  14. Yashima K, Ashfaq R, Nowak J, et al.: Telomerase activity and expression of its RNA component in cervical lesions. Cancer 82: 1319–1327, 1998
    Google Scholar
  15. Zhang W, Kapusta LR, Slingerland JM, Klotz LH: Telomerase activity in prostate cancer, prostatic intraepithelial hyperplasia, and benign prostatic epithelium. Cancer Res 58: 619–921, 1998
    Google Scholar
  16. Zakian VA: Telomeres: beginning to understand the end. Science 270: 1601–1607, 1995
    Google Scholar
  17. Greider CW, Blackburn EH: A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337: 331–337, 1989
    Google Scholar
  18. Kim NW, Piatyszek MA, Prowse KR, et al.: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011–2015, 1994
    Google Scholar
  19. Rhyu MS: Telomeres, telomerases and immortality. J Natl Cancer Inst 87: 884–894, 1995
    Google Scholar
  20. Greider CW: Telomerase activity, cell proliferation and cancer. Proc Natl Acad Sci USA 95: 90–92, 1998
    Google Scholar
  21. Write WE, Shay JW: Telomere positional effects and the regulation of cellular senescence. Trends Genet 8: 193–197, 1992
    Google Scholar
  22. Shay JW, Bacchetti S: A survey of telomerase in human cancer. Eur J Cancer 33: 787–791, 1997
    Google Scholar
  23. Shay JW, Gazdar AF: Telomerase in the early detection of cancer. J Clin Pathol 50: 106–109, 1997
    Google Scholar
  24. Breslow RA, Shay JW, Gazdar AF, Srivastava S: Telomerase and early detection of cancer: a national cancer institute workshop. J Natl Cancer Inst 89: 618–623, 1997
    Google Scholar
  25. Hiyama E, Gollahon LS, Kataoka T, et al.: Telomerase activity in human breast tumors. J Natl Cancer Inst 88: 116–122, 1996
    Google Scholar
  26. Bednarek AK, Sahin A, Brenner AJ, Johnston DA, Aldaz CM: Analysis of telomerase activity levels in breast cancer: positive detection in the in situ breast carcinoma stage. Clin Cancer Res 3: 11–16. 1997
    Google Scholar
  27. Yashima K, Milchgrub S, Gollahon LS, et al.:Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast cancer. Clin Cancer Res 4: 229–234, 1998
    Google Scholar
  28. Devilee P, Cornellisse C: Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1198: 113–130, 1994
    Google Scholar
  29. Umbricht CB, Sherman M, Dome J, Adey C, Kim N, Sukumar S: Telomerase activity in preinvasive breast cancer. Proc Am Assoc Cancer Res 39: 543, 1998
    Google Scholar
  30. Klingelhutz AJ: Telomerase activation and cancer. J Mol Med 75: 45–49, 1997
    Google Scholar
  31. Belair CD, Yager TR, Lopez PM, Reznikoff CA: Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 94: 13677–13682, 1997
    Google Scholar
  32. Prowse KR, Greider CW: Development and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci 92: 4818–4822, 1995
    Google Scholar

Download references